Eintrag weiter verarbeiten
A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry
Gespeichert in:
Zeitschriftentitel: | Measuring Business Excellence |
---|---|
Personen und Körperschaften: | , , , |
In: | Measuring Business Excellence, 17, 2013, 4, S. 88-101 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Emerald
|
Schlagwörter: |
author_facet |
Mehralian, Gholamhossein Akhavan, Peyman Reza Rasekh, Hamid Rajabzadeh Ghatari, Ali Mehralian, Gholamhossein Akhavan, Peyman Reza Rasekh, Hamid Rajabzadeh Ghatari, Ali |
---|---|
author |
Mehralian, Gholamhossein Akhavan, Peyman Reza Rasekh, Hamid Rajabzadeh Ghatari, Ali |
spellingShingle |
Mehralian, Gholamhossein Akhavan, Peyman Reza Rasekh, Hamid Rajabzadeh Ghatari, Ali Measuring Business Excellence A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry Organizational Behavior and Human Resource Management General Business, Management and Accounting |
author_sort |
mehralian, gholamhossein |
spelling |
Mehralian, Gholamhossein Akhavan, Peyman Reza Rasekh, Hamid Rajabzadeh Ghatari, Ali 1368-3047 Emerald Organizational Behavior and Human Resource Management General Business, Management and Accounting http://dx.doi.org/10.1108/mbe-10-2012-0053 <jats:sec> <jats:title content-type="abstract-heading">Purpose</jats:title> <jats:p> – <jats:italic>During the last decade, intellectual capital (IC) has been widely considered as a critical tool to deliver successful business in an intensive knowledge environment. The main goal of this paper is therefore to develop and prioritize human capital indicators as an important component of IC in knowledge-based industries.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Design/methodology/approach</jats:title> <jats:p> – <jats:italic>Based on an extensive literature review, a valid and reliable questionnaire was designed. In order to gather data, it was sent out to 108 participants from academia and universities who were well qualified in pharmaceutical practice. Besides statistical analysis, the authors also used fuzzy TOPSIS technique as a MADM model in order to extract prioritization of indicators.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Findings</jats:title> <jats:p> – <jats:italic>The analysis indicates that there is little difference between academic and university respondents. Furthermore, the fuzzy TOPSIS results show that participants have high concerns especially about knowledge and skills of managers and employees.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Research limitations/implications</jats:title> <jats:p> – <jats:italic>The findings offer valuable insights in evaluating the state of human capital state as a key component of IC in knowledge- based industry.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Practical implications</jats:title> <jats:p> – <jats:italic>There is an immediate need that the policy makers and corporate managers wake up to the need and start to measure and disclose the intangible assets of firms. Intellectual capital measurement is also of primary interest for top executives of pharmaceutical firms in Iran.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Originality/value</jats:title> <jats:p> – <jats:italic>This is an initial and pioneering study to develop a valid tool to evaluate IC in the Iranian pharmaceutical industry. The present study provides a new aspect of performance measurement for research-based industries in emerging economies and would be a good topic for further research.</jats:italic> </jats:p> </jats:sec> A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry Measuring Business Excellence |
doi_str_mv |
10.1108/mbe-10-2012-0053 |
facet_avail |
Online |
finc_class_facet |
Wirtschaftswissenschaften |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEwOC9tYmUtMTAtMjAxMi0wMDUz |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEwOC9tYmUtMTAtMjAxMi0wMDUz |
institution |
DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 FID-BBI-DE-23 DE-105 DE-14 DE-Ch1 DE-L229 |
imprint |
Emerald, 2013 |
imprint_str_mv |
Emerald, 2013 |
issn |
1368-3047 |
issn_str_mv |
1368-3047 |
language |
English |
mega_collection |
Emerald (CrossRef) |
match_str |
mehralian2013aframeworkforhumancapitalindicatorsinknowledgebasedindustriesevidencefrompharmaceuticalindustry |
publishDateSort |
2013 |
publisher |
Emerald |
recordtype |
ai |
record_format |
ai |
series |
Measuring Business Excellence |
source_id |
49 |
title |
A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_unstemmed |
A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_full |
A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_fullStr |
A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_full_unstemmed |
A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_short |
A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_sort |
a framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
topic |
Organizational Behavior and Human Resource Management General Business, Management and Accounting |
url |
http://dx.doi.org/10.1108/mbe-10-2012-0053 |
publishDate |
2013 |
physical |
88-101 |
description |
<jats:sec>
<jats:title content-type="abstract-heading">Purpose</jats:title>
<jats:p> – <jats:italic>During the last decade, intellectual capital (IC) has been widely considered as a critical tool to deliver successful business in an intensive knowledge environment. The main goal of this paper is therefore to develop and prioritize human capital indicators as an important component of IC in knowledge-based industries.</jats:italic>
</jats:p>
</jats:sec>
<jats:sec>
<jats:title content-type="abstract-heading">Design/methodology/approach</jats:title>
<jats:p> – <jats:italic>Based on an extensive literature review, a valid and reliable questionnaire was designed. In order to gather data, it was sent out to 108 participants from academia and universities who were well qualified in pharmaceutical practice. Besides statistical analysis, the authors also used fuzzy TOPSIS technique as a MADM model in order to extract prioritization of indicators.</jats:italic>
</jats:p>
</jats:sec>
<jats:sec>
<jats:title content-type="abstract-heading">Findings</jats:title>
<jats:p> – <jats:italic>The analysis indicates that there is little difference between academic and university respondents. Furthermore, the fuzzy TOPSIS results show that participants have high concerns especially about knowledge and skills of managers and employees.</jats:italic>
</jats:p>
</jats:sec>
<jats:sec>
<jats:title content-type="abstract-heading">Research limitations/implications</jats:title>
<jats:p> – <jats:italic>The findings offer valuable insights in evaluating the state of human capital state as a key component of IC in knowledge- based industry.</jats:italic>
</jats:p>
</jats:sec>
<jats:sec>
<jats:title content-type="abstract-heading">Practical implications</jats:title>
<jats:p> – <jats:italic>There is an immediate need that the policy makers and corporate managers wake up to the need and start to measure and disclose the intangible assets of firms. Intellectual capital measurement is also of primary interest for top executives of pharmaceutical firms in Iran.</jats:italic>
</jats:p>
</jats:sec>
<jats:sec>
<jats:title content-type="abstract-heading">Originality/value</jats:title>
<jats:p> – <jats:italic>This is an initial and pioneering study to develop a valid tool to evaluate IC in the Iranian pharmaceutical industry. The present study provides a new aspect of performance measurement for research-based industries in emerging economies and would be a good topic for further research.</jats:italic>
</jats:p>
</jats:sec> |
container_issue |
4 |
container_start_page |
88 |
container_title |
Measuring Business Excellence |
container_volume |
17 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792329566048485384 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T13:10:38.311Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+framework+for+human+capital+indicators+in+knowledge-+based+industries%3A+evidence+from+pharmaceutical+industry&rft.date=2013-11-11&genre=article&issn=1368-3047&volume=17&issue=4&spage=88&epage=101&pages=88-101&jtitle=Measuring+Business+Excellence&atitle=A+framework+for+human+capital+indicators+in+knowledge-+based+industries%3A+evidence+from+pharmaceutical+industry&aulast=Rajabzadeh+Ghatari&aufirst=Ali&rft_id=info%3Adoi%2F10.1108%2Fmbe-10-2012-0053&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792329566048485384 |
author | Mehralian, Gholamhossein, Akhavan, Peyman, Reza Rasekh, Hamid, Rajabzadeh Ghatari, Ali |
author_facet | Mehralian, Gholamhossein, Akhavan, Peyman, Reza Rasekh, Hamid, Rajabzadeh Ghatari, Ali, Mehralian, Gholamhossein, Akhavan, Peyman, Reza Rasekh, Hamid, Rajabzadeh Ghatari, Ali |
author_sort | mehralian, gholamhossein |
container_issue | 4 |
container_start_page | 88 |
container_title | Measuring Business Excellence |
container_volume | 17 |
description | <jats:sec> <jats:title content-type="abstract-heading">Purpose</jats:title> <jats:p> – <jats:italic>During the last decade, intellectual capital (IC) has been widely considered as a critical tool to deliver successful business in an intensive knowledge environment. The main goal of this paper is therefore to develop and prioritize human capital indicators as an important component of IC in knowledge-based industries.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Design/methodology/approach</jats:title> <jats:p> – <jats:italic>Based on an extensive literature review, a valid and reliable questionnaire was designed. In order to gather data, it was sent out to 108 participants from academia and universities who were well qualified in pharmaceutical practice. Besides statistical analysis, the authors also used fuzzy TOPSIS technique as a MADM model in order to extract prioritization of indicators.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Findings</jats:title> <jats:p> – <jats:italic>The analysis indicates that there is little difference between academic and university respondents. Furthermore, the fuzzy TOPSIS results show that participants have high concerns especially about knowledge and skills of managers and employees.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Research limitations/implications</jats:title> <jats:p> – <jats:italic>The findings offer valuable insights in evaluating the state of human capital state as a key component of IC in knowledge- based industry.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Practical implications</jats:title> <jats:p> – <jats:italic>There is an immediate need that the policy makers and corporate managers wake up to the need and start to measure and disclose the intangible assets of firms. Intellectual capital measurement is also of primary interest for top executives of pharmaceutical firms in Iran.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Originality/value</jats:title> <jats:p> – <jats:italic>This is an initial and pioneering study to develop a valid tool to evaluate IC in the Iranian pharmaceutical industry. The present study provides a new aspect of performance measurement for research-based industries in emerging economies and would be a good topic for further research.</jats:italic> </jats:p> </jats:sec> |
doi_str_mv | 10.1108/mbe-10-2012-0053 |
facet_avail | Online |
finc_class_facet | Wirtschaftswissenschaften |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEwOC9tYmUtMTAtMjAxMi0wMDUz |
imprint | Emerald, 2013 |
imprint_str_mv | Emerald, 2013 |
institution | DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, FID-BBI-DE-23, DE-105, DE-14, DE-Ch1, DE-L229 |
issn | 1368-3047 |
issn_str_mv | 1368-3047 |
language | English |
last_indexed | 2024-03-01T13:10:38.311Z |
match_str | mehralian2013aframeworkforhumancapitalindicatorsinknowledgebasedindustriesevidencefrompharmaceuticalindustry |
mega_collection | Emerald (CrossRef) |
physical | 88-101 |
publishDate | 2013 |
publishDateSort | 2013 |
publisher | Emerald |
record_format | ai |
recordtype | ai |
series | Measuring Business Excellence |
source_id | 49 |
spelling | Mehralian, Gholamhossein Akhavan, Peyman Reza Rasekh, Hamid Rajabzadeh Ghatari, Ali 1368-3047 Emerald Organizational Behavior and Human Resource Management General Business, Management and Accounting http://dx.doi.org/10.1108/mbe-10-2012-0053 <jats:sec> <jats:title content-type="abstract-heading">Purpose</jats:title> <jats:p> – <jats:italic>During the last decade, intellectual capital (IC) has been widely considered as a critical tool to deliver successful business in an intensive knowledge environment. The main goal of this paper is therefore to develop and prioritize human capital indicators as an important component of IC in knowledge-based industries.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Design/methodology/approach</jats:title> <jats:p> – <jats:italic>Based on an extensive literature review, a valid and reliable questionnaire was designed. In order to gather data, it was sent out to 108 participants from academia and universities who were well qualified in pharmaceutical practice. Besides statistical analysis, the authors also used fuzzy TOPSIS technique as a MADM model in order to extract prioritization of indicators.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Findings</jats:title> <jats:p> – <jats:italic>The analysis indicates that there is little difference between academic and university respondents. Furthermore, the fuzzy TOPSIS results show that participants have high concerns especially about knowledge and skills of managers and employees.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Research limitations/implications</jats:title> <jats:p> – <jats:italic>The findings offer valuable insights in evaluating the state of human capital state as a key component of IC in knowledge- based industry.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Practical implications</jats:title> <jats:p> – <jats:italic>There is an immediate need that the policy makers and corporate managers wake up to the need and start to measure and disclose the intangible assets of firms. Intellectual capital measurement is also of primary interest for top executives of pharmaceutical firms in Iran.</jats:italic> </jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-heading">Originality/value</jats:title> <jats:p> – <jats:italic>This is an initial and pioneering study to develop a valid tool to evaluate IC in the Iranian pharmaceutical industry. The present study provides a new aspect of performance measurement for research-based industries in emerging economies and would be a good topic for further research.</jats:italic> </jats:p> </jats:sec> A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry Measuring Business Excellence |
spellingShingle | Mehralian, Gholamhossein, Akhavan, Peyman, Reza Rasekh, Hamid, Rajabzadeh Ghatari, Ali, Measuring Business Excellence, A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry, Organizational Behavior and Human Resource Management, General Business, Management and Accounting |
title | A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_full | A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_fullStr | A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_full_unstemmed | A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_short | A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_sort | a framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
title_unstemmed | A framework for human capital indicators in knowledge- based industries: evidence from pharmaceutical industry |
topic | Organizational Behavior and Human Resource Management, General Business, Management and Accounting |
url | http://dx.doi.org/10.1108/mbe-10-2012-0053 |